Resumen:
|
[EN] Accurate blood glucose (BG) forecasting is key in diabetes management, as it allows preventive actions to mitigate harmful hypoglycemic/hyperglycemic episodes. Considering the encouraging results obtained by seasonal ...[+]
[EN] Accurate blood glucose (BG) forecasting is key in diabetes management, as it allows preventive actions to mitigate harmful hypoglycemic/hyperglycemic episodes. Considering the encouraging results obtained by seasonal stochastic models in proof-of-concept studies, this work assesses the methodology in two datasets (open-loop and closed-loop) recorded in free-living conditions. First, similar postprandial glycemic profiles are grouped together with fuzzy C-means clustering. Then, a seasonal stochastic model is identified for each cluster. Finally, real-time BG forecasting is performed by weighting each model's prediction. The proposed methodology (named C-SARIMA) is compared to other linear and nonlinear black-box methods: autoregressive integrated moving average (ARIMA), its variant with input (ARIMAX), a feed-forward neural network (NN), and its modified version (NN-X) fed by BG, insulin, and carbohydrates (timing and dosing) information for several prediction horizons (PHs). In the open-loop dataset, C-SARIMA grants a median root-mean-squared error (RMSE) of 20.13 mg/dL (PH = 30) and 27.23 mg/dL (PH = 45), not significantly different from ARIMA and NN. Over a longer PH, C-SARIMA achieves an RMSE = 31.96 mg/dL (PH = 60) and RMSE = 33.91 mg/dL (PH = 75), significantly outperforming the ARIMA and NN, without significant differences from the ARIMAX for PH >= 45 and the NN-X for PH >= 60. Similar results hold on the closed-loop dataset: for PH = 30 and 45 min, the C-SARIMA achieves an RMSE = 21.63 mg/dL and RMSE = 29.67 mg/dL, not significantly different from the ARIMA and NN. On longer PH, the C-SARIMA outperforms the ARIMA for PH > 45 and the NN for PH > 60 without significant differences from the ARIMAX for PH >= 45. Although using less input information, the C-SARIMA achieves similar performance to other prediction methods such as the ARIMAX and NN-X and outperforming the CGM-only approaches on PH > 45min.
[-]
|
Agradecimientos:
|
This work was partially supported by the project "A noninvasive tattoo-based continuous GLUCOse Monitoring electronic system FOR Type-1 diabetes individuals (GLUCOMFORT)" (initiative "PRIN: Progetti di Rilevante Interesse ...[+]
This work was partially supported by the project "A noninvasive tattoo-based continuous GLUCOse Monitoring electronic system FOR Type-1 diabetes individuals (GLUCOMFORT)" (initiative "PRIN: Progetti di Rilevante Interesse Nazionale", call 2020, project ID: 2020X7XX2P) and through the initiative "Departments of Excellence" (Law 232/2016); Grant DPI2016-78831-C2-1-R funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe", Grant PID2019-107722RB-C21 funded by MCIN/AEI/10.13039/501100011033, and the mobility Grant PRX19/00463 funded by MCIN/AEI/10.13039/501100011033 for a research stay of J. Bondia at the University of Padova.
[-]
|